Lifecore Biomedical Targets European CDMO Market with Strategic Conference Participation
Event summary
- Lifecore Biomedical will participate in CDMO Live Europe conference in Rotterdam, Netherlands, from May 19-21, 2026.
- Ryan Swanson, Ph.D., Lifecore’s director of manufacturing science and technology, will participate in a panel discussion titled 'The Tech Transfer Playbook: Right First Time Strategies' on May 19, 2026.
- The company will host meetings with prospective customers to discuss process development and manufacturing services for injectables programs.
- Lifecore Biomedical is a fully integrated injectables CDMO with over 40 years of expertise in sterile injectable pharmaceutical products.
The big picture
Lifecore Biomedical's participation in CDMO Live Europe underscores its strategic focus on expanding its presence in the European market. As a leading CDMO for injectables, the company aims to capitalize on the growing demand for sterile injectable pharmaceutical products. The conference provides a platform for Lifecore to showcase its capabilities and forge new partnerships, potentially driving revenue growth and market share.
What we're watching
- Market Expansion
- How Lifecore's participation in CDMO Live Europe will impact its market penetration in the European CDMO sector.
- Strategic Positioning
- Whether Lifecore can leverage this conference to secure new contracts and strengthen its position as a leading CDMO for injectables.
- Execution Risk
- The pace at which Lifecore can convert conference discussions into tangible business opportunities.
Related topics